Neogenomics (NEO) Convertible Debt (2020 - 2026)

Neogenomics (NEO) has 7 years of Convertible Debt data on file, last reported at $374.2 million in Q2 2026.

• Quarterly Convertible Debt rose 9.72% year-over-year to $374.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $374.2 million (up 9.72% YoY) and the FY2025 annual result came in at $341.9 million, changed 0.45% from the prior year.
• Convertible Debt climbed to $374.2 million in Q2 2026, from $342.2 million in the prior quarter.
• In the past five years, Convertible Debt ranged from a high of $538.9 million in Q1 2024 to a low of $339.6 million in Q2 2024.
• A 5-year average of $440.3 million and a median of $453.7 million in 2022 frame the typical range for Convertible Debt.
• Annual changes were most pronounced in 2025 — Convertible Debt plunged 36.78% — and 2026, when it climbed 9.72%.
• Tracing NEO's Convertible Debt over 5 years: stood at $535.3 million in 2022, then grew by 0.54% to $538.2 million in 2023, then sank by 36.76% to $340.3 million in 2024, then gained by 0.45% to $341.9 million in 2025, then advanced by 9.47% to $374.2 million in 2026.
• The last three Convertible Debt figures came in at $374.2 million (Q2 2026), $342.2 million (Q1 2026), and $341.9 million (Q4 2025), per Business Quant data.